Overall, analyses of miR-182-5p, Cyld and Foxo1 expression levels in publicly available datasets in human HCC showed consistent results with those obtained from our experiments with liver tissues and tumors from NAFLD/HCC mouse models. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatotic liver disease.